Literature DB >> 8234266

Serine-173 of the Epstein-Barr virus ZEBRA protein is required for DNA binding and is a target for casein kinase II phosphorylation.

J L Kolman1, N Taylor, D R Marshak, G Miller.   

Abstract

An Epstein-Barr virus-encoded protein, ZEBRA, mediates the switch from latency to the viral lytic life cycle. ZEBRA's domain structure and DNA binding specificity resemble that of cellular transcriptional activators such as c-Fos/c-Jun. We show that ZEBRA, like c-Jun, is phosphorylated by casein kinase II (CKII). The principal site of phosphorylation is serine-173 (S173), five amino acids upstream of the basic DNA recognition domain. CKII phosphorylation abrogated ZEBRA's capacity to bind its target DNA sequences. S173 is a functional component of ZEBRA's DNA binding domain, since mutation of S173 to alanine (S173A) reduced DNA binding in vitro to 10% of wild-type levels. Transcriptional activation of a native viral promoter in vivo by mutant S173A was also reduced markedly. Reversible phosphorylation of S173 is likely to be an important means of regulating ZEBRA's activity in vivo.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8234266      PMCID: PMC47724          DOI: 10.1073/pnas.90.21.10115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  Transcriptional synergy by the Epstein-Barr virus transactivator ZEBRA.

Authors:  M Carey; J Kolman; D A Katz; L Gradoville; L Barberis; G Miller
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

2.  Mitotic phosphorylation of the Oct-1 homeodomain and regulation of Oct-1 DNA binding activity.

Authors:  N Segil; S B Roberts; N Heintz
Journal:  Science       Date:  1991-12-20       Impact factor: 47.728

Review 3.  The regulation of transcription by phosphorylation.

Authors:  T Hunter; M Karin
Journal:  Cell       Date:  1992-08-07       Impact factor: 41.582

4.  Myc and Max associate in vivo.

Authors:  E M Blackwood; B Lüscher; R N Eisenman
Journal:  Genes Dev       Date:  1992-01       Impact factor: 11.361

5.  Casein kinase II inhibits the DNA-binding activity of Max homodimers but not Myc/Max heterodimers.

Authors:  S J Berberich; M D Cole
Journal:  Genes Dev       Date:  1992-02       Impact factor: 11.361

6.  Fos is phosphorylated by p34cdc2, cAMP-dependent protein kinase and protein kinase C at multiple sites clustered within regulatory regions.

Authors:  C Abate; D R Marshak; T Curran
Journal:  Oncogene       Date:  1991-12       Impact factor: 9.867

7.  Jun is phosphorylated by several protein kinases at the same sites that are modified in serum-stimulated fibroblasts.

Authors:  S J Baker; T K Kerppola; D Luk; M T Vandenberg; D R Marshak; T Curran; C Abate
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

8.  Viral proteins associated with the Epstein-Barr virus transactivator, ZEBRA.

Authors:  D A Katz; R P Baumann; R Sun; J L Kolman; N Taylor; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

9.  Casein kinase II is a negative regulator of c-Jun DNA binding and AP-1 activity.

Authors:  A Lin; J Frost; T Deng; T Smeal; N al-Alawi; U Kikkawa; T Hunter; D Brenner; M Karin
Journal:  Cell       Date:  1992-09-04       Impact factor: 41.582

10.  Phosphorylation of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA.

Authors:  M Daibata; R E Humphreys; T Sairenji
Journal:  Virology       Date:  1992-06       Impact factor: 3.616

View more
  21 in total

1.  Phosphorylation of simian cytomegalovirus assembly protein precursor (pAPNG.5) and proteinase precursor (pAPNG1): multiple attachment sites identified, including two adjacent serines in a casein kinase II consensus sequence.

Authors:  S M Plafker; A S Woods; W Gibson
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  Amino acids in the basic domain of Epstein-Barr virus ZEBRA protein play distinct roles in DNA binding, activation of early lytic gene expression, and promotion of viral DNA replication.

Authors:  Lee Heston; Ayman El-Guindy; Jill Countryman; Charles Dela Cruz; Henri-Jacques Delecluse; George Miller
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

3.  A protein kinase activity associated with Epstein-Barr virus BGLF4 phosphorylates the viral early antigen EA-D in vitro.

Authors:  M R Chen; S J Chang; H Huang; J Y Chen
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

4.  Phosphoacceptor site S173 in the regulatory domain of Epstein-Barr Virus ZEBRA protein is required for lytic DNA replication but not for activation of viral early genes.

Authors:  Ayman El-Guindy; Lee Heston; Henri-Jacques Delecluse; George Miller
Journal:  J Virol       Date:  2007-01-10       Impact factor: 5.103

5.  A replication function associated with the activation domain of the Epstein-Barr virus Zta transactivator.

Authors:  R T Sarisky; Z Gao; P M Lieberman; E D Fixman; G S Hayward; S D Hayward
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

6.  A Noncanonical Basic Motif of Epstein-Barr Virus ZEBRA Protein Facilitates Recognition of Methylated DNA, High-Affinity DNA Binding, and Lytic Activation.

Authors:  Erin Weber; Olga Buzovetsky; Lee Heston; Kuan-Ping Yu; Kirsten M Knecht; Ayman El-Guindy; George Miller; Yong Xiong
Journal:  J Virol       Date:  2019-06-28       Impact factor: 5.103

7.  Comparing transcriptional activation and autostimulation by ZEBRA and ZEBRA/c-Fos chimeras.

Authors:  J L Kolman; N Taylor; L Gradoville; J Countryman; G Miller
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

8.  Cell cycle stage-specific phosphorylation of the Epstein-Barr virus immortalization protein EBNA-LP.

Authors:  M K Kitay; D T Rowe
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

9.  Identification of human cytomegalovirus UL84 virus- and cell-encoded binding partners by using proteomics analysis.

Authors:  Yang Gao; Kelly Colletti; Gregory S Pari
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

10.  DNA-binding-defective mutants of the Epstein-Barr virus lytic switch activator Zta transactivate with altered specificities.

Authors:  E K Flemington; J P Lytle; C Cayrol; A M Borras; S H Speck
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.